Abstract
Objectives
Mucormycosis is a life-threatening condition that can be present in diabetes mellitus. Although the rhino-orbito-cerebral form is the most common, other types may be developed as well.
Case presentation
The present study reports two children with diabetes who had the cutaneous and pulmonary forms of mucormycosis. The first case was a four-year-old boy without a history of diabetes admitted due to loss of consciousness and a necrotic lesion on his hand. The second was an 11-year-old boy with dyspnea, polyuria, and polydipsia who had developed diabetes two years before, and whose chest X-ray had shown a pulmonary lesion. Both cases were treated with surgical implementation and appropriate antifungal therapy.
Conclusions
Mucormycosis is a fatal condition that can even be present at the onset of diabetes mellitus. Therefore, any diabetic patient with any presentation of respiratory symptoms such as coughs, or any cutaneous lesion should be examined carefully for mucormycosis after which prompt treatment must begin.
-
Conflict of interest: The authors declare that they have no conflict of interest.
-
Ethical statement: The research related to human use has been complied with all the relevant national regulations, institutional policies and in accordance with the tenets of the Helsinki Declaration, and has been approved by the authors’ institutional review board or equivalent committee.
References
1. Jevalikar, G, Sudhanshu, S, Mahendru, S, Sarma, S, Farooqui, KJ, Mithal, A, et al.. Cutaneous mucormycosis as a presenting feature of type 1 diabetes in a boy–case report and review of the literature. J Pediatr Endocrinol Metabol 2018;31:689–92. https://doi.org/10.1515/jpem-2017-0404.Search in Google Scholar PubMed
2. Kasper, D, Fauci, A, Hauser, S, Longo, D, Jameson, J, Loscalzo, J. Harrison’s principles of internal medicine. New York: Mcgraw-hill; 2015, 19e.Search in Google Scholar
3. Bennett, JE, Dolin, R, Blaser, MJ. Mandell, Douglas, and Bennett’s principles and practice of infectious diseases: 2-volume set. Philadelphia: Elsevier Health Sciences; 2014.Search in Google Scholar
4. Claustre, J, Larcher, R, Jouve, T, Truche, A-S, Nseir, S, Cadiet, J, et al.. Mucormycosis in intensive care unit: surgery is a major prognostic factor in patients with hematological malignancy. Ann Intensive Care 2020;10:1–12. https://doi.org/10.1186/s13613-020-00673-9.Search in Google Scholar PubMed PubMed Central
5. Thomas, L, Tay, SY, Howard, D, Falhammar, HJC. Mucormycosis in a 40-year-old woman with diabetic ketoacidosis. Can Med Assoc J 2020;192:E431–3. https://doi.org/10.1503/cmaj.191364.Search in Google Scholar PubMed PubMed Central
6. De Pauw, B, Walsh, TJ, Donnelly, JP, Stevens, DA, Edwards, JE, Calandra, T, et al.. Revised definitions of invasive fungal disease from the European organization for research and treatment of cancer/invasive fungal infections cooperative group and the national institute of allergy and infectious diseases mycoses study group (EORTC/MSG) consensus group. Clin Infect Dis 2008;46:1813–21. https://doi.org/10.1086/588660.Search in Google Scholar PubMed PubMed Central
7. Roden, MM, Zaoutis, TE, Buchanan, WL, Knudsen, TA, Sarkisova, TA, Schaufele, RL, et al.. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis 2005;41:634–53. https://doi.org/10.1086/432579.Search in Google Scholar PubMed
8. Guo, S, Liu, H, Tang, X, Yang, HJPI. Clinical characteristics and prognoses of pulmonary mucormycosis in four children. Pediatr Invest 2019;3:223–7. https://doi.org/10.1002/ped4.12161.Search in Google Scholar PubMed PubMed Central
9. Francis JR, VP, Bryant, P, Blyth, C. Mucormycosis in children: review and recommendations for management. J Pediatric Infect Dis Soc 2018;7:159–64. https://doi.org/10.1093/jpids/pix107.Search in Google Scholar PubMed
10. Pana, ZD, Seidel, D, Skiada, A, Groll, AH, Petrikkos, G, Cornely, OA, et al.. Invasive mucormycosis in children: an epidemiologic study in European and non-European countries based on two registries. BMC Infect Dis 2016;16:667. https://doi.org/10.1186/s12879-016-2005-1.Search in Google Scholar PubMed PubMed Central
11. Elzein, F, Albarrag, A, Kalam, K, Arafah, M, Al-Baadani, A, Eltayeb, N, et al.. Mucormycosis: an 8-year experience of a tertiary care centre in Saudi Arabia. J Infect Public Health 2020;13:1774–9.10.1016/j.jiph.2020.08.002Search in Google Scholar PubMed
© 2021 Walter de Gruyter GmbH, Berlin/Boston
